Meaghan K McGeary

10PUBLICATIONS
54CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)AllergyReproduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 21, 2025
Lipophilic Statins Deplete GPX4 to Promote Ferroptosis and Sensitize Cancer Cells to Immune Checkpoint Blockade.

Ronan Talty, Veronica T Brooks, Meaghan K McGeary

|Aug 19, 2025
Cytotoxic CD8+ T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma That Drives Antitumor Immunity.

Karine Flem-Karlsen, Ronan Talty, Meaghan K McGeary

|Nov 26, 2024
Setdb1 Loss Induces Type I Interferons and Immune Clearance of Melanoma.

Meaghan K McGeary, William Damsky, Andrew J Daniels

|Jul 21, 2023
Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 Resistance.

Irina Krykbaeva, Kate Bridges, William Damsky

|Jun 09, 2023
Setdb1 -loss induces type-I interferons and immune clearance of melanoma.

Meaghan K McGeary, William Damsky, Andrew Daniels

|Jun 06, 2022
Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis.

William Damsky, Alice Wang, Daniel J Kim

Pageof 2